EnLiSense Patents – Insights and Stats (Updated 2023)

EnLiSense has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. The United States of America is where EnLiSense has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of EnLiSense.

EnLiSense was founded in 2014. EnLiSense provides wearable diagnostic tools for assessing sweat biomarkers. It helps in the diagnosis of cardiovascular illnesses as well as the non-invasive monitoring of blood glucose. It provides applications for point-of-care, ambulatory, and home settings for the diagnostic and prognostic assessment of infectious and chronic illnesses.

Do read about some of the most popular patents of EnLiSense which have been covered by us in this article and also you can find EnLiSense patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over EnLiSense patent portfolio.

How many patents does EnLiSense have?

EnLiSense has a total of 7 patents globally. These patents belong to 6 unique patent family. Out of 7 patents, 6 patents are active.

How Many Patents did EnLiSense File Every Year?

EnLiSense Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEnLiSense Applications FiledEnLiSense Patents Granted
20231
20212
20191
201811
20172
20151

How many EnLiSense patents are Alive/Dead?

EnLiSense Patent Portfolio

 How Many Patents did EnLiSense File in Different Countries?

EnLiSense filled all their patents in United States of America.

Countries in which Envisagenics Filed Patents

CountryPatent
United States of America7

Where are Research Centers of EnLiSense Patents Located?

The Research Center of EnLiSense Patents is the United States of America.

Best EnLiSense Patents

WO2018075824A1 is the most popular patent in the EnLiSense portfolio. It has received 6 citations so far from companies like Medtronic, InnoTech Precision Medicine, Cardiai Technologies.

Below is the list of 10 most cited patents of EnLiSense:

Publication NumberCitation Count
WO2018075824A16
US10006882B23
US20210325380A13
US20200054259A12
US20190069818A12
US20220160265A11

List of EnLiSense Patents

EnLiSense PatentTitle
US11782055B2Multi-Configurable Sensing Array And Methods Of Using Same
US10006882B2Biosensing System And Methods Using Electron-Ionic Mechanisms At Fluid-Sensor Interfaces
US20220160265A1Machine-Learning Based Biosensor System
US20210325380A1Disease Diagnostics Using A Multi-Configurable Sensing Array
US20200054259A1High Density Analog Multipexing
US20190069818A1Wearable Biosensors With Room Temperature Ionic Liquid Buffer
WO2018075824A1Multi-Configurable Sensing Array And Methods Of Using Same

What are EnLiSense key innovation segments?

What Technologies are Covered by EnLiSense?

The chart below distributes patents filed by EnLiSense in different countries on the basis of the technology protected in patents. It also represents the markets where EnLiSense thinks it’s important to protect particular technology inventions.

R&D Focus: How has EnLiSense search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by EnLiSense?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.